1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Buhai Wang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer Sintilimab, quadrivalent HPV vaccine - Uterine Cervical Neoplasms, Cervical Cancer | Phase 2 | Unknown | Buhai Wang | 20 | 2019-07-31 | 2019-09-20 |
Uterine Cervical Neoplasms (1)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · sintilimab (1)
China (1)
Yuechao Wu (1)
PMID 29095678, PMID 29787422, PMID 29967015, PMID 30826965, PMID 39608975